Benitec Biopharma CEO and managing director Peter French said that the commencement of this clinical trial of TT-034 represents a landmark in the company’s history. "The trial is
Current investors Atlas Venture and Johnson & Johnson Development (JJDC) led the financing round. Rodin will use the new funds to advance its pipeline of selective epigenetic modulators
Mylan received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prophylaxis
Spectrum Pharmaceuticals chairman and CEO Rajesh Shrotriya said that SPI-2012 is the highest priority drug in the company’s pipeline because of its unique technology, and its potential to
Prior to the meeting with the MPA on 26 May 2014, InSite Vision had submitted substantial preliminary BromSite information to the Agency including CMC (chemistry, manufacturing, and controls)
Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive portfolio of assays and disease models, underpinned by internationally recognised expertise, the company supports each
These studies are the important first step in determining the safety and tolerability of new drugs. They test how drugs are absorbed into the body, and the amount
The company also received a second patent for ZORVOLEX (diclofenac) capsules covering its manufacturing method. ZORVOLEX and TIVORBEX were approved in October 2013 and February 2014, respectively, by
Fibrocell’s clinical program for RDEB will utilize PCT’s manufacturing expertise and resources to implement the production process for transfer and clinical manufacturing of genetically-modified cell therapies. The manufacturing
The settlement enables Boehringer Ingelheim to focus solely on its mission of improving patients’ lives and allows the company to avoid the distraction and uncertainty of lengthy litigation.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.